Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Zinc -
Here's an interesting one to look at, very similar concept though well behind NNVC --
http://israel21c.org/health/new-israeli-tactic-makes-deadly-viruses-commit-suicide/
Also, publishing does not advance the company at this point, I would rather they focus their time and effort on getting into human trials. Success there, of course, trumps everything else.
thanks for the good laugh...
he's the one that posts the lions share of "research about competitive technologies."
Excellent!
reading clues is the nature of emerging biotech investing.
No, I don't believe tox has been delayed 6 to 12 months. That doesn't align with the rest of the clues, which again you seem to be missing.
that's not even close to what we have been saying. What you continue to refuse to recognize is the dramatic improvement in odds that the treatment will transfer effectively to humans that results from the unique mode of action. Most all drugs work by altering cell function.... the fact that cides work in the blood with no altering of cell function changes the risk profile significantly.
before or after the beverage flowing from the Kahuna's tub?
some are able to distinguish relevant risk factors, some are not.
some are able to read clues on actual progress, some are not.
I might need help, I need a lot of space!
Can I rent space in your backpack?
yes, we have had several years of that "interesting bias". The bashers here have no interest in logic and reason but prefer to twist, distort, and slander.... which suggests an ulterior agenda. It moves from one topic to another in a never ending cycle. I applaud your tireless efforts though.
they will have eye drops for free virus in the eye and an anti-viral ointment for herpes virus in the genital blisters.
They may be able to "cure" the herpes keratitis but the genital herpes is impossible to cure because the virus hides in the nerve roots.
Though each genital outbreak should be cleared quickly and it is presumed that since a smaller number of viral particles will go back to the nerve roots, the outbreaks will be fewer in number and less intense.
We are in desperate need of an eye roll emoticon here.
Yes!
actually, the very conservative rendering in the 10K said they could be "completed" by 2015.
to complain about those salaries is very short sighted as that is no guaranteed long term income stream. Either the company succeeds within a couple of years and we all get rich (and I would happily give them another raise), or they fail, in which case you can take comfort in the fact that those salaries were only paid for 2 years.
the order got pulled, so obviously they didn't REALLY have that much for sale there.
started at 50k, probably only a temporary wall. You don't typically telegraph an offer that large unless you want the price lower. If I had 50k shares to sell, I certainly wouldn't throw it up there for everybody to see on Level II. It's easy to disguise large orders if you want to.
I asked Dr. Seymour about DRACO last year, and as I recall he felt it was a brilliant bit of science but of no consequence to NNVC as they were likely 5 yrs behind. It only worked in one case, I think, when given after infection but he did acknowledge that it would probably be improved over time.
I think I misinterpreted this statement from the 10K earlier today--
It's confusingly written but I think they are just explaining why they are having to scale up the existing facility in the first place.... due to delays in getting equipment for the cGMP facility. They don't want to have to wait for that equipment to get tox started. Yes, tox materials will come from the existing lab.
a clean room, such as the one that is being built offsite to go into the new facility, is not required for tox studies.
a clean room is not required for tox studies.
No, existing lab.
yes, that should read 2014.
it is confusingly written, but I believe they are referring to equipment to be used in the new cGMP facility, not the existing lab.
I think they are just explaining why they had to go with the scale-up operations with the existing lab.
If they are talking 12-18 mos to finish preclinical studies on FluCide injectable, it does look like a 6 to 12 month delay on getting tox started.
the second post I put up describes it in detail.
and here --
edit
Echo -
when these things occur, and we ARE headed for a temporary shutdown, essential obligations still get paid.
you've got algos on the sell side, you can see it in the constant flashing in and out on the offer.
the stock only went up what, 6-fold since your dire predictions earlier in the year? I guess when the Bunny sticks his head out the hole we know the bottom is in.
still missing the obvious clues...